Search research articles
Contact Us
Filters
Showing results (81-90 of 820) with videos related to
Page
of 82
Sort By:
Drugs & Aging
|
October 31, 2013
Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence
Massimo Volpe, Giuliano Tocci
Giornale Italiano Di Cardiologia (2006)
|
December 24, 2014
[The PARADIGM-HF study]
Luigi Tavazzi, Massimo Volpe
Frontiers in Physiology
|
June 6, 2022
Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
Massimo Volpe, Speranza Rubattu
JACC. Cardiovascular Interventions
|
June 9, 2022
Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma?
Massimo Volpe, Giovanna Gallo
European Heart Journal
|
June 16, 2023
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?
Giovanna Liuzzo, Massimo Volpe
European Heart Journal
|
June 27, 2025
Weekly Journal Scan: A global observational study shows how modifying five cardiovascular risk factors at midlife may affect lifespan and healthspan
Daniela Pedicino, Massimo Volpe
European Heart Journal
|
August 1, 2023
The promise of a new orally active body weight reducer
Massimo Volpe, Daniela Pedicino
European Heart Journal
|
February 21, 2021
Iron heart
Massimo Volpe, Carlo Patrono
International Journal of Molecular Sciences
|
August 21, 2019
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
Speranza Rubattu, Massimo Volpe
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
April 22, 2017
Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents?
Massimo Volpe, Vittoria Mastromariona
Page
of 82
Search research articles
Search
Showing results (81-90 of 820) with videos related to
Sort By:
Page
of 82
Drugs & Aging
|
October 31, 2013
Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence
Massimo Volpe, Giuliano Tocci
Giornale Italiano Di Cardiologia (2006)
|
December 24, 2014
[The PARADIGM-HF study]
Luigi Tavazzi, Massimo Volpe
Frontiers in Physiology
|
June 6, 2022
Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
Massimo Volpe, Speranza Rubattu
JACC. Cardiovascular Interventions
|
June 9, 2022
Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma?
Massimo Volpe, Giovanna Gallo
European Heart Journal
|
June 16, 2023
24 Hour blood pressure monitoring is a better predictor of mortality than clinic blood pressure in a large cohort of primary care patients: what is the impact on clinical practice?
Giovanna Liuzzo, Massimo Volpe
European Heart Journal
|
June 27, 2025
Weekly Journal Scan: A global observational study shows how modifying five cardiovascular risk factors at midlife may affect lifespan and healthspan
Daniela Pedicino, Massimo Volpe
European Heart Journal
|
August 1, 2023
The promise of a new orally active body weight reducer
Massimo Volpe, Daniela Pedicino
European Heart Journal
|
February 21, 2021
Iron heart
Massimo Volpe, Carlo Patrono
International Journal of Molecular Sciences
|
August 21, 2019
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
Speranza Rubattu, Massimo Volpe
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|
April 22, 2017
Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents?
Massimo Volpe, Vittoria Mastromariona
Page
of 82